First Time Loading...

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 365.08 USD 0.02%
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one WST stock under the Base Case scenario is 349.72 USD. Compared to the current market price of 365.08 USD, West Pharmaceutical Services Inc is Overvalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

WST Relative Value
Base Case
349.72 USD
Overvaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.1
P/S
P/S
Price to Sales
9.1
vs History
42
vs Industry
20
Median 3Y
9.2
Median 5Y
8.9
Industry
3.9
Forward
8.8
More Details
46.9
P/E
P/E
Price to Earnings
46.9
vs History
49
vs Industry
9
Median 3Y
46.5
Median 5Y
46.9
Industry
31.1
Forward
47.5
More Details
35.2
P/OCF
P/OCF
Price to OCF
35.2
vs History
57
vs Industry
16
Median 3Y
36.1
Median 5Y
36.1
Industry
23.3
More Details
69.4
P/FCFE
P/FCFE
Price to FCFE
69.4
vs History
33
vs Industry
11
Median 3Y
69.3
Median 5Y
61.3
Industry
27.4
More Details
9.9
P/B
P/B
Price to Book Value
9.9
vs History
46
vs Industry
7
Median 3Y
10
Median 5Y
9.8
Industry
2.5
More Details
8.9
EV/S
EV/S
Enterprise Value to Sales
8.9
vs History
42
vs Industry
20
Median 3Y
9
Median 5Y
8.7
Industry
3.8
Forward
8.6
More Details
24
EV/GP
EV/GP
Enterprise Value to Gross Profit
24
vs History
42
vs Industry
14
Median 3Y
23.7
Median 5Y
23.5
Industry
7.9
More Details
32.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
32.5
vs History
44
vs Industry
10
Median 3Y
32.4
Median 5Y
31.5
Industry
17.2
Forward
30.5
More Details
39.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
39.5
vs History
38
vs Industry
11
Median 3Y
38.1
Median 5Y
37.9
Industry
22.7
Forward
37.4
More Details
34.5
EV/OCF
EV/OCF
Enterprise Value to OCF
34.5
vs History
57
vs Industry
15
Median 3Y
35.3
Median 5Y
35.2
Industry
21.4
More Details
67.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
67.7
vs History
38
vs Industry
9
Median 3Y
65.8
Median 5Y
61.7
Industry
27.9
More Details
9.5
EV/IC
EV/IC
Enterprise Value to IC
9.5
vs History
52
vs Industry
9
Median 3Y
10.1
Median 5Y
9.6
Industry
2.4
More Details

Multiples Across Competitors

WST Competitors Multiples
West Pharmaceutical Services Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
West Pharmaceutical Services Inc
NYSE:WST
26.7B USD 9.1 46.9 32.5 39.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
222B USD 5.2 37 22.9 33.5
US
Danaher Corp
NYSE:DHR
183.3B USD 4.2 22.7 16.5 20.4
CH
Lonza Group AG
SIX:LONN
37.3B CHF 5.6 57 19.6 28.7
US
Agilent Technologies Inc
NYSE:A
41.2B USD 6.1 33.4 26.7 32.1
US
IQVIA Holdings Inc
NYSE:IQV
41B USD 2.7 30.2 16.5 25.4
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.5B USD 7 33.5 23.5 26.1
IE
ICON PLC
NASDAQ:ICLR
25.8B USD 3.1 37.7 17 26.2
FR
Sartorius Stedim Biotech SA
PAR:DIM
19B EUR 7 74.5 32.1 52.7
US
Waters Corp
NYSE:WAT
19.1B USD 6.5 29.8 20.6 24.5

See Also

Summary
WST intrinsic value, competitors valuation, and company profile.
DCF Valuation
WST stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WST stock valuation using valuation multiples.
Wall Street Estimates
WST price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WST stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.